Article
In a survey released by Community Oncology Alliance (COA), the majority of physicians reported concern over proposals to reform the Medicare Part B program
In a survey released by Community Oncology Alliance (COA), the majority of physicians reported concern over proposals to reform the Medicare Part B program. The survey included 100 oncologists/hematologists and 50 rheumatologists. COA commissioned the survey to gain insight into physician perspectives of 2 proposals set forth by the Medicare Payment Advisory Commission and mentioned by President Donald Trump in his blueprint to lower drug prices and out-of-pocket costs.
The survey inquired about opinions on the revamped Competitive Acquisition Program, in which select private vendors would negotiate drug prices with manufacturers, and a proposal to shift prescription drugs currently paid under Medicare Part B into the Medicare Part D program.
Physicians indicated that they are worried the proposed changes would reduce care choices, increase costs and administrative burden, and decrease physician autonomy.
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Supplemental Dental, Vision Benefits May Not Justify MA Payments for VA-Covered Veterans